GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Fushilai Pharmaceutical Co Ltd (SZSE:301258) » Definitions » Market Cap

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Market Cap : ¥2,543.8 Mil (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Fushilai Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Suzhou Fushilai Pharmaceutical Co's share price for the quarter that ended in Mar. 2024 was ¥25.48. Suzhou Fushilai Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 91.7 Mil. Therefore, Suzhou Fushilai Pharmaceutical Co's market cap for the quarter that ended in Mar. 2024 was ¥2,335.8 Mil.

Suzhou Fushilai Pharmaceutical Co's quarterly market cap declined from Sep. 2023 (¥3,657.6 Mil) to Dec. 2023 (¥2,959.1 Mil) and declined from Dec. 2023 (¥2,959.1 Mil) to Mar. 2024 (¥2,335.8 Mil).

Suzhou Fushilai Pharmaceutical Co's annual market cap increased from Dec. 2021 (¥0.0 Mil) to Dec. 2022 (¥3,598.0 Mil) but then declined from Dec. 2022 (¥3,598.0 Mil) to Dec. 2023 (¥2,959.1 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Suzhou Fushilai Pharmaceutical Co's Enterprise Value for Today is ¥1,193.4 Mil.


Suzhou Fushilai Pharmaceutical Co Market Cap Historical Data

The historical data trend for Suzhou Fushilai Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Fushilai Pharmaceutical Co Market Cap Chart

Suzhou Fushilai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3,598.05 2,959.11

Suzhou Fushilai Pharmaceutical Co Quarterly Data
Jun18 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,717.22 3,604.46 3,657.63 2,959.11 2,335.75

Competitive Comparison of Suzhou Fushilai Pharmaceutical Co's Market Cap

For the Biotechnology subindustry, Suzhou Fushilai Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Fushilai Pharmaceutical Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Fushilai Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Suzhou Fushilai Pharmaceutical Co's Market Cap falls into.



Suzhou Fushilai Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Suzhou Fushilai Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥32.28*91.67
=¥2,959.1

Suzhou Fushilai Pharmaceutical Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥25.48*91.67
=¥2,335.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Fushilai Pharmaceutical Co  (SZSE:301258) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Suzhou Fushilai Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Suzhou Fushilai Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Business Description

Traded in Other Exchanges
N/A
Address
No. 16, Haiwang Road, New Material Industrial Park, Jiangsu Province, Changshu, CHN, 215500
Suzhou Fushilai Pharmaceutical Co Ltd is engaged in the Research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have significant effects in anti-oxidation, anti-aging, and blood sugar improvement.
Executives
Qian Yi Supervisors

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Headlines

No Headlines